Go online to PeerView.com/TTU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in psychiatry discusses the evidence for the use of GABA-modulating neuroactive steroids for major depressive disorder. Upon completion of this CE activity, participants will be able to: Summarize the evidence supporting a role for GABAergic dysfunction and altered neuroactive steroid signaling in major depressive disorder (MDD), Recognize the burden of MDD and the impact of delayed or suboptimal treatment on patient outcomes, Evaluate recent safety and efficacy data related to emerging treatment options for MDD, recognizing potential implications for the future treatment landscape.

Anita H. Clayton, MD - Recent Advances and Novel Options in Depression: Reviewing the Evidence for GABA-Modulating Neuroactive Steroids for Major Depressive Disorder

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

Share Anita H. Clayton, MD - Recent Advances and Novel Options in Depression: Reviewing the Evidence for GABA-Modulating Neuroactive Steroids for Major Depressive Disorder

Sign up to save your podcasts

Anita H. Clayton, MD - Recent Advances and Novel Options in Depression: Reviewing the Evidence for GABA-Modulating Neuroactive Steroids for Major Depressive Disorder

Anita H. Clayton, MD - Recent Advances and Novel Options in Depression: Reviewing the Evidence for GABA-Modulating Neuroactive Steroids for Major Depressive Disorder

More shows like PeerView Neuroscience & Psychiatry CME/CNE/CPE Video Podcast

PeerView Endocrinology & Diabetes CME/CNE/CPE Audio Podcast

PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast

PeerView Gastroenterology CME/CNE/CPE Audio Podcast

PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast

PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast

PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

PeerView Gastroenterology CME/CNE/CPE Video Podcast

PeerView Internal Medicine CME/CNE/CPE Video Podcast

PeerView Endocrinology & Diabetes CME/CNE/CPE Video Podcast

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast

PeerView Infectious Diseases CME/CNE/CPE Audio Podcast

PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio Podcast

PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video Podcast

PeerView Infectious Diseases CME/CNE/CPE Video Podcast

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

PeerView Immunology & Transplantation CME/CNE/CPE Video Podcast

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

PeerView Clinical Pharmacology CME/CNE/CPE Video